Tumor Ablation Therapy Devices Market Research Reveals Strong 14.2% CAGR Outlook Through 2030
The Business Research Company's Tumor Ablation Therapy Devices Market Report 2026 – Market Size, Trends, And Global
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
The Business Research Company’s Tumor Ablation Therapy Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, September 1, 2026 /EINPresswire.com/ — “The tumor ablation therapy devices market is experiencing swift expansion as advancements in cancer treatment continue to evolve. Increasing cancer cases worldwide and innovative therapeutic approaches are driving interest in these minimally invasive devices, which are becoming more prominent in oncology care. Below is a detailed overview of market size, growth factors, regional dominance, and key trends influencing this sector.
Market Size and Growth Prospects for Tumor Ablation Therapy Devices
The market for tumor ablation therapy devices has seen rapid development in recent years. It is projected to increase from $0.82 billion in 2025 to $0.95 billion in 2026, representing a compound annual growth rate (CAGR) of 15.0%. This historical growth stems from several factors, including rising cancer incidence rates, the expansion of oncology treatment centers, greater adoption of minimally invasive therapies, improved access to advanced imaging technologies, and a growing preference for treatments that preserve organs.
Download a free sample of the tumor ablation therapy devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR
Looking ahead, the tumor ablation therapy devices market is expected to expand even more quickly, reaching $1.61 billion by 2030 with a CAGR of 14.2%. This forecasted growth is supported by increased investments in precision oncology, heightened demand for outpatient cancer treatments, advancements in ablation technology, enhanced integration of imaging with therapeutic systems, and a stronger emphasis on personalized cancer care. Key trends shaping the market include wider use of minimally invasive ablation procedures, increased reliance on image-guided ablation, growing application of organ-specific ablation technologies, expansion of percutaneous treatment methods, and a sharper focus on precision oncology techniques.
Understanding Tumor Ablation Therapy Devices and Their Applications
Tumor ablation therapy devices are minimally invasive tools designed to treat tumors primarily found in organs like the kidney, liver, and lung. These devices operate by targeting and destroying cancer cells while sparing the surrounding healthy tissue, making them a preferred option in many clinical scenarios.
View the full tumor ablation therapy devices market report:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR
Primary Factors Propelling Tumor Ablation Therapy Devices Market Growth
A major driver behind the tumor ablation therapy devices market is the increasing prevalence of cancer globally. Cancer ranks as the second leading cause of death worldwide, responsible for about one in every six deaths. This rising cancer burden is largely fueled by aging populations since older individuals face a higher lifetime risk of developing various cancers. Tumor ablation procedures are widely used to manage tumors in the lung, liver, kidney, and bone, offering an effective treatment alternative.
For example, in 2023, the American Cancer Society Inc., a US-based nonprofit health organization, projected 1,958,310 new cancer diagnoses in the United States alone, reflecting an increase from 1,918,030 new cases reported in 2022. These numbers highlight the growing need for effective interventions. Tumor ablation is particularly valuable for patients who do not respond to chemotherapy or radiotherapy, further driving demand for these devices.
Dominant Regions in the Tumor Ablation Therapy Devices Market
In terms of regional market share, North America led the global tumor ablation therapy devices market in 2025, holding the largest portion of the global market. Asia-Pacific followed as the second largest market, showing significant potential for future growth. The market report also covers regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.
Expanded capabilities in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery



